The 2 mg, single-dose, sterilized prefilled syringe provides physicians with a new way to administer EYLEA that requires fewer preparation steps compared to vials, said the drugmaker, which plans to supply EYLEA prefilled syringe this year.
Shares were last up 3%.
Price: 304.78, Change: +8.91, Percent Change: +3.01
|Sector Update: Health Care Stocks Outperform But Sti...|
|Sector Update: More Erosion for Tech Stocks in Late ...|
|Denmark's Genmab Chairman Pettersson to Step Down in...|
|Market Chatter: Google Resists Demands From Attorney...|
|Update: Puma Biotechnology Drops After Decline in Fl...|